Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/15/20
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 04/16/21
End: 06/26/21
Due: 06/26/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A. | NCT04456387 | Zhengzhou Gensciences Inc | user2@example.com | None | 2020-10-15 | 2021-09-30 | 2022-09-30 | - | - | 2025-07-14 |
| Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A | NCT04845399 | Zhengzhou Gensciences Inc | user2@example.com | None | 2021-04-16 | 2021-06-26 | 2022-06-26 | - | - | 2025-07-14 |